Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 304

1.

Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.

Zhang X, Chuai Y, Nie W, Wang A, Dai G.

Cochrane Database Syst Rev. 2017 Nov 27;11:CD012035. doi: 10.1002/14651858.CD012035.pub2. Review.

PMID:
29178132
2.

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.

Desborough M, Hadjinicolaou AV, Chaimani A, Trivella M, Vyas P, Doree C, Hopewell S, Stanworth SJ, Estcourt LJ.

Cochrane Database Syst Rev. 2016 Oct 31;10:CD012055. Review.

3.

Thrombopoietin mimetics for patients with myelodysplastic syndromes.

Dodillet H, Kreuzer KA, Monsef I, Skoetz N.

Cochrane Database Syst Rev. 2017 Sep 30;9:CD009883. doi: 10.1002/14651858.CD009883.pub2. Review.

PMID:
28962071
4.

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.

Desborough M, Estcourt LJ, Doree C, Trivella M, Hopewell S, Stanworth SJ, Murphy MF.

Cochrane Database Syst Rev. 2016 Aug 22;(8):CD010982. doi: 10.1002/14651858.CD010982.pub2. Review.

5.

Prophylactic platelet transfusions prior to surgery for people with a low platelet count.

Estcourt LJ, Malouf R, Doree C, Trivella M, Hopewell S, Birchall J.

Cochrane Database Syst Rev. 2018 Sep 17;9:CD012779. doi: 10.1002/14651858.CD012779.pub2. Review.

PMID:
30221749
6.

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF.

Cochrane Database Syst Rev. 2015 Nov 18;(11):CD010983. doi: 10.1002/14651858.CD010983.pub2. Review.

7.

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P, Murphy MF.

Cochrane Database Syst Rev. 2015 Oct 27;(10):CD010984. doi: 10.1002/14651858.CD010984.pub2. Review.

8.

TPO receptor agonist for chronic idiopathic thrombocytopenic purpura.

Zeng Y, Duan X, Xu J, Ni X.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008235. doi: 10.1002/14651858.CD008235.pub2. Review.

PMID:
21735426
9.

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Crighton GL, Estcourt LJ, Wood EM, Trivella M, Doree C, Stanworth S.

Cochrane Database Syst Rev. 2015 Sep 30;(9):CD010981. doi: 10.1002/14651858.CD010981.pub2. Review.

10.

Pathogen-reduced platelets for the prevention of bleeding.

Estcourt LJ, Malouf R, Hopewell S, Trivella M, Doree C, Stanworth SJ, Murphy MF.

Cochrane Database Syst Rev. 2017 Jul 30;7:CD009072. doi: 10.1002/14651858.CD009072.pub3. Review.

11.

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.

Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy MF, Tinmouth A, Heddle N.

Cochrane Database Syst Rev. 2012 May 16;(5):CD004269. doi: 10.1002/14651858.CD004269.pub3. Review.

PMID:
22592695
12.

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.

Estcourt LJ, Desborough M, Brunskill SJ, Doree C, Hopewell S, Murphy MF, Stanworth SJ.

Cochrane Database Syst Rev. 2016 Mar 15;3:CD009733. doi: 10.1002/14651858.CD009733.pub3. Review.

13.

Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.

Chan KK, Glenny AM, Weldon JC, Furness S, Worthington HV, Wakeford H.

Cochrane Database Syst Rev. 2015 Dec 1;(12):CD010341. doi: 10.1002/14651858.CD010341.pub2. Review.

PMID:
26625332
14.

Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.

Estcourt LJ, Malouf R, Trivella M, Fergusson DA, Hopewell S, Murphy MF.

Cochrane Database Syst Rev. 2017 Jan 27;1:CD011305. doi: 10.1002/14651858.CD011305.pub2. Review.

15.

Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.

van Dalen EC, Mank A, Leclercq E, Mulder RL, Davies M, Kersten MJ, van de Wetering MD.

Cochrane Database Syst Rev. 2016 Apr 24;4:CD006247. doi: 10.1002/14651858.CD006247.pub3. Review.

PMID:
27107610
16.

Pathogen-reduced platelets for the prevention of bleeding.

Butler C, Doree C, Estcourt LJ, Trivella M, Hopewell S, Brunskill SJ, Stanworth S, Murphy MF.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD009072. doi: 10.1002/14651858.CD009072.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Jul 30;7:CD009072.

PMID:
23543569
17.

Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.

Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, Di Renzo N, Santoro C, Di Nicola M, Veneri D, Simonetti F, Liberati AM, Ferla V, Paoloni F, Crea E, Volpetti S, Tuniz E, Fanin R.

Am J Hematol. 2016 May;91(5):E293-5. doi: 10.1002/ajh.24341. Epub 2016 Apr 4.

18.

Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy.

Riley P, Glenny AM, Worthington HV, Littlewood A, Clarkson JE, McCabe MG.

Cochrane Database Syst Rev. 2015 Dec 23;(12):CD011552. doi: 10.1002/14651858.CD011552.pub2. Review.

PMID:
26695736
19.

Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.

Skoetz N, Will A, Monsef I, Brillant C, Engert A, von Tresckow B.

Cochrane Database Syst Rev. 2017 May 25;5:CD007941. doi: 10.1002/14651858.CD007941.pub3. Review.

PMID:
28541603
20.

Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.

Skoetz N, Bohlius J, Engert A, Monsef I, Blank O, Vehreschild JJ.

Cochrane Database Syst Rev. 2015 Dec 21;(12):CD007107. doi: 10.1002/14651858.CD007107.pub3. Review.

Supplemental Content

Support Center